Water-activated, pH-controlled patch in transdermal administration of timolol - II. Drug absorption and skin irritation

By Sutinen R.   Paronen P.   Saano V.   Urtti A.  

European Journal of Pharmaceutical Sciences, Vol. 11, Iss. 1, 2000-07 ,pp. : 25-31

Elsevier

Access to resources Recommend Favorite

Antibody-targeted Polymer-doxorubicin Conjugates with pH-controlled Activation

By Ulbrich K.   Etrych T.   Chytil P.   Jelínková M.   Říhová B.  

Journal of Drug Targeting, Vol. 12, Iss. 8, 2004-09 ,pp. : 477-489

Informa Healthcare

Access to resources Recommend Favorite

Transdermal Administration of Radiolabelled [14C]Rotigotine by a Patch Formulation: A Mass Balance Trial

By Cawello Willi  

Clinical Pharmacokinetics, Vol. 46, Iss. 10, 2007-01 ,pp. : 851-857

Adis International

Access to resources Recommend Favorite

Buprenorphine 5, 10 and 20 μg/h Transdermal Patch: A Guide to Its Use in Chronic Non-Malignant Pain

By Plosker Greg L.   Lyseng-Williamson Katherine A.  

CNS Drugs, Vol. 26, Iss. 4, 2012-04 ,pp. : 367-373

Adis International

Access to resources Recommend Favorite

Buprenorphine 5, 10 and 20 μg/h Transdermal Patch: A Review of its Use in the Management of Chronic Non-Malignant Pain

By Plosker Greg L.  

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2491-2509

Adis International

Access to resources Recommend Favorite